https://wiki.tradeville.ro/index.php?action=history&feed=atom&title=MERSANA_THERAPEUTICS_INCMERSANA THERAPEUTICS INC - Revizia istoricului2026-04-06T05:22:19ZIstoricul versiunilor pentru această pagină din wikiMediaWiki 1.39.2https://wiki.tradeville.ro/index.php?title=MERSANA_THERAPEUTICS_INC&diff=431115&oldid=prevAdmin: Pagină nouă: Pagina dedicata companiei MERSANA THERAPEUTICS INC listata cu simbolul US.MRSN ==Descriere companie== Mersana Therapeutics, Inc. (http://www.mersana.com/) is a clinical stage biopharmaceutical company. The Company is focused on developing antibody drug conjugates (ADCs). The Company’s platforms include Dolaflexin and Dolasynthen. Its product candidates include upifitamab rilsodotin (UpRi, XMT-1536) and XMT-1592. The Company’s early stage programs include B7-H4-targeted D...2024-09-18T18:13:55Z<p>Pagină nouă: Pagina dedicata companiei MERSANA THERAPEUTICS INC listata cu simbolul US.MRSN ==Descriere companie== Mersana Therapeutics, Inc. (http://www.mersana.com/) is a clinical stage biopharmaceutical company. The Company is focused on developing antibody drug conjugates (ADCs). The Company’s platforms include Dolaflexin and Dolasynthen. Its product candidates include upifitamab rilsodotin (UpRi, XMT-1536) and XMT-1592. The Company’s early stage programs include B7-H4-targeted D...</p>
<p><b>Pagină nouă</b></p><div>Pagina dedicata companiei MERSANA THERAPEUTICS INC listata cu simbolul US.MRSN<br />
<br />
==Descriere companie==<br />
Mersana Therapeutics, Inc. (http://www.mersana.com/) is a clinical stage biopharmaceutical company. The Company is focused on developing antibody drug conjugates (ADCs). The Company’s platforms include Dolaflexin and Dolasynthen. Its product candidates include upifitamab rilsodotin (UpRi, XMT-1536) and XMT-1592. The Company’s early stage programs include B7-H4-targeted Dolasynthen ADC, XMT-1660, as well as candidates leveraging the Immunosynthen platform. UpRi is an ADC utilizing the Company’s Dolaflexin platform and targeting NaPi2b, which is an antigen broadly expressed in ovarian cancer and non-small cell lung cancer (NSCLC) adenocarcinoma. XMT-1592 uses the Company’s Dolasynthen platform and targets NaPi2b.<br />
<br />
==Grafic actiuni companie==<br />
<iframe key="tradeville" path="graficSimbol/US.MRSN" /><br />
<br />
==Ultimele stiri despre MERSANA THERAPEUTICS INC (US.MRSN)==<br />
<dynamicpagelist><br />
category=US.MRSN<br />
count=10<br />
order=descending<br />
addfirstcategorydate=false<br />
</dynamicpagelist><br />
<br />
[[Categorie:US.MRSN]][[Categorie:Stiri despre companii]]</div>Admin